Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases.

Authors: Reyes-Long S, Roldan-Valadez E, Cortes-Altamirano JL, Clavijo-Cornejo D, Alfaro-Rodriguez A.

DOI: 10.7759/cureus.98237

Abstract Summary

MicroRNAs play a crucial role in Alzheimer’s and Parkinson’s cognitive decline. This bibliometric analysis of 7,722 studies identified 100 most-cited articles (2015-2021), revealing 40 “Hyperclassics” with over 250 citations each. The US led research output, with Harvard Medical School as top contributor. Review articles dominated high-impact publications, highlighting the field’s consolidation phase.

Why Brain? 🧠

MicroRNAs show promise as biomarkers for early detection of cognitive decline in Alzheimer’s and Parkinson’s diseases, with this analysis identifying key research trends and collaboration opportunities.

License: CC BY.

The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.